Traws Pharma, Inc. (TRAW) Net margin 2015–2024
Traws Pharma, Inc. (TRAW) net profit margin by fiscal year — reported net income divided by reported revenue.
328.7%FY2024 · since FY2015: -354.6% → 328.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 328.7% | +74011.4 pp |
| FY2023 | -73682.7% | -65298.7 pp |
| FY2022 | -8384.1% | +7.1 pp |
| FY2021 | -8391.2% | -1239.4 pp |
| FY2020 | -7151.8% | +3738.7 pp |
| FY2019 | -10890.5% | -9905.5 pp |
| FY2018 | -985.0% | +690.3 pp |
| FY2017 | -1675.3% | +1385.9 pp |
| FY2016 | -3061.2% | -2706.6 pp |
| FY2015 | -354.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice